参考文献/References:
［参 考 文 献］
［1］ Luo J, Yan Z, Liu Q, et al. Endovascular placement of iodine- 125 seed Strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein［J］. J Vasc Interv Radiol, 2011, 22: 479- 489.
［2］ 吴林霖， 罗剑钧， 颜志平， 等. 门静脉支架及经动脉药物治疗栓塞联合或未联合血管内植入碘-125粒子条治疗肝癌合并门静脉主干癌栓的比较［J］. 中华肝脏病杂志， 2012， 20： 915- 919．
［3］ 刘清欣， 颜志平， 李 说， 等． 125I粒子条联合门静脉支架及化疗栓塞治疗原发性肝癌合并门静脉癌栓［J］． 介入放射学杂志， 2009， 18： 593- 595．
［4］ 方主亭， 颜志平， 罗剑钧， 等． 腔内植入125I粒子条联合经肝动脉化疗栓塞术治疗肝癌合并广泛性门静脉癌栓的疗效观察［J］． 中华肝脏病杂志， 2013， 21： 146- 149．
［5］ Shimizu T, Saijo N. Common toxicity criteria: version 2.0, an improved reference for grading the adverse reaction of cancer treatment［J］. Nihon Rinsho, 2003, 61: 937- 942.
［6］ 蒋 奡， 王忠敏， 张丽云， 等． 125I 粒子持续照射对Sw1990及Panc-1细胞生物学效应的影响［J］． 介入放射学杂志， 2013， 22： 490- 493．
［7］ 刘 健， 张福君， 吴沛宏， 等． CT导向下125I粒子植入治疗肝门区肝癌［J］． 介入放射学杂志， 2005， 14： 606- 609．
［8］ 张 辉， 莫日根． TACE 联合CT 导向下125I 放射性粒子植入治疗肝癌［J］． 介入放射学杂志， 2009， 18： 702-704．
［9］ Monajemi TT, Clements CM, Sloboda RS. Dose calculation for permanent prostate implants incorporating spatially anisotropic linearly time- resolving edema［J］. Med Phys, 2011, 38: 2289- 2298.
［10］ Zhang FJ, Li CX, Jiao DC, et al. CT guided 125I odine seed implantation for portal vein tumor thrombus in primary hepatocellular carcinoma［J］. Chin Med J（Engl）, 2008, 121: 2410- 2414.
［11］ Nag S, DeHaan M, Scruggs G, et al. Long- term follow- up of patients of intrahepatic malignancies treated with iodine- 125 brachytherapy［J］. Int J Radiat Oncol Biol Phys, 2006, 64: 736- 744.
［12］ 吕 进， 曹秀峰. 碘-125粒子植入治疗肝细胞癌的剂量学［J］. 世界华人消化杂志， 2008， 16： 3295- 3298.
［13］ 李 说， 颜志平， 张 雯， 等． 兔门静脉主干内植入连续排列125I粒子条的实验研究［J］． 介入放射学杂志， 2009， 18： 607- 611．
相似文献/References:
[1]程洁敏,王建华.喜树碱微球化疗栓塞治疗原发性肝癌10例报告[J].介入放射学杂志,1993,(01):47.
[2]卢丽琴,陈方宏,袁建华,等.晚期肝癌伴门脉癌栓的介入治疗[J].介入放射学杂志,1996,(03):136.
[3]程洪涛,郭晨阳,黎海亮,等.ＴＡＣＥ联合射频消融治疗原发性肝癌疗效的影响因素分析[J].介入放射学杂志,2012,(03):216.
,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ＣＴｇｕｉｄｅｄ ｐｅｒｃｕｔａｎｅｏｕｓ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｔｈｅ ｔｒｅａｔｍｅｎｔ ｏｆ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａｎ ａｎａｌｙｓｉｓ ｏｆ ｆａｃｔｏｒｓ ａｆｆｅｃｔｉｎｇ ｔｈｅ ｔｈｅｒａｐｅｕｔｉｃ ｒｅｓｕｌｔ [J].journal interventional radiology,2012,(09):216.
[4]张晓前,郭 鹏,党之俊,等.金龙胶囊联合介入疗法治疗原发性肝癌临床观察[J].介入放射学杂志,2012,(03):249.
,,et al.Ｋｉｎｇｌｏｎｇ ｃａｐｓｕｌｅｓ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｉｎｔｅｒｖｅｎｔｉｏｎａｌ ｔｈｅｒａｐｙ ｆｏｒ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ｃｌｉｎｉｃａｌ ｏｂｓｅｒｖａｔｉｏｎ [J].journal interventional radiology,2012,(09):249.
[5]姚全军,胡鸿涛,黎海亮,等.Ｃ臂ＣＴ成像在乏血供原发性肝癌诊疗中的临床应用[J].介入放射学杂志,2012,(04):305.
,,et al.Ｔｈｅ ｃｌｉｎｉｃａｌ ａｐｐｌｉｃａｔｉｏｎ ｏｆ Ｃ ａｒｍ ＣＴ ｉｍａｇｉｎｇ ｉｎ ｄｉａｇｎｏｓｉｎｇ ａｎｄ ｔｒｅａｔｉｎｇ ｈｙｐｏｖａｓｃｕｌａｒ ｐｒｉｍａｒｙ ｈｅｐａｔｉｃ ｃａｒｃｉｎｏｍａｓ [J].journal interventional radiology,2012,(09):305.
[6]帕哈尔丁·白克热,杨树法,黄伍奎,等.肝动脉化疗栓塞联合射频消融术治疗３０例原发性大肝癌的疗效评价[J].介入放射学杂志,2012,(04):322.
,,et al.ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｒａｄｉｏｆｒｅｑｕｅｎｃｙ ａｂｌａｔｉｏｎ ｆｏｒ ｍａｓｓｉｖｅ ｐｒｉｍａｒｙ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ： ａ ｃｌｉｎｉｃａｌ ｔｈｅｒａｐｅｕｔｉｃ ｅｖａｌｕａｔｉｏｎ [J].journal interventional radiology,2012,(09):322.
[7]杨永波,程红岩.肝动脉化疗栓塞治疗中碘油用量的现状与研究进展[J].介入放射学杂志,2012,(04):348.
.Ｔｈｅ ｖｏｌｕｍｅ ｏｆ Ｌｉｐｉｏｄｏｌ ｕｓｅｄ ｉｎ ＴＡＣＥ： ｉｔｓ ｃｕｒｒｅｎｔ ｓｉｔｕａｔｉｏｎ ａｎｄ ｒｅｓｅａｒｃｈ ｐｒｏｇｒｅｓｓ [J].journal interventional radiology,2012,(09):348.
[8]高 嵩,朱旭,杨仁杰,等. ＴＡＣＥ联合奥沙利铂、氟尿嘧啶、亚叶酸钙肝动脉化疗治疗中晚期原发性肝癌[J].介入放射学杂志,2012,(05):377.
,,et al. ＴＡＣＥ ｃｏｍｂｉｎｅｄ ｗｉｔｈ ｈｅｐａｔｉｃ ａｒｔｅｒｉａｌ ｉｎｆｕｓｉｏｎ ｃｈｅｍｏｔｈｅｒａｐｙ ｕｓｉｎｇ ｏｘａｌｉｐｌａｔｉｎ， ５ｆｌｕｏｒｏｕｒａｃｉｌ ａｎｄ ｆｏｌｉｎｉｃ ａｃｉｄ ｆｏｒ ｉｎｔｅｒｍｅｄｉａｔｅ ａｎｄ ａｄｖａｎｃｅｄ ｈｅｐａｔｏｃｅｌｌｕｌａｒ ｃａｒｃｉｎｏｍａｓ[J].journal interventional radiology,2012,(09):377.
[9]刘 昕,吕维富,鲁 东,等. 动脉介入栓塞治疗肝癌破裂出血[J].介入放射学杂志,2012,(07):586.
LIU Xin,LV Wei- fu,LU Dong,et al. Interventional treatment of hepatic bleeding due to spontaneous rupture of hepatocellular carcinoma[J].journal interventional radiology,2012,(09):586.
[10]张志良,杨学东,温阿明,等. 经动脉化疗栓塞联合伽玛刀治疗原发性肝癌的疗效评价[J].介入放射学杂志,2012,(07):596.
ZHANG Zhi- liang,YANG Xue- dong,WEN A-ming,et al. Evaluation of TACE combined with gamma?蛳 knife radiotherapy for primary hepatocellular carcinoma[J].journal interventional radiology,2012,(09):596.
[11]姚红响,陈根生,诸葛英,等.肝动脉化疗栓塞联合ＣＴ引导射频消融序贯治疗中小肝癌的临床应用[J].介入放射学杂志,2012,(04):301.
,,et al.Ｓｅｑｕｅｎｔｉａｌ ｔｒｅａｔｍｅｎｔ ｗｉｔｈ ＴＡＣＥ ａｎｄ ＣＴｇｕｉｄｅｄ ＲＦＡ ｆｏｒ ｓｍａｌｌ ａｎｄ ｍｏｄｅｒａｔｅ ｓｉｚｅｄ ＨＣＣ [J].journal interventional radiology,2012,(09):301.
[12]赵许亚,周 石.TACE联合经皮瘤内注射碘油吡柔比星乳剂治疗中晚期肝癌疗效分析[J].介入放射学杂志,2012,(08):675.
ZHAO Xu- ya,ZHOU Shi.. Transcatheter artery chemoembolization combined with percutaneous intratumoral injection of Lipiodol emulsion of pirarubicin for advanced hepatocellular carcinomas： an analysis of clinical efficacy[J].journal interventional radiology,2012,(09):675.
[13]沈 杰,于学涛,范晓强,等. TACE和微波凝固术联合重组人血管内皮抑素治疗大肝癌25例的临床研究[J].介入放射学杂志,2013,(12):995.
SHEN Jie,YU Xue? tao,FAN Xiao? qiang,et al.TACE and microwave coagulation combined with recombinant human endostatin for the treatment of large liver cancer： a clinical study in 25 cases[J].journal interventional radiology,2013,(09):995.
[14]纪岩磊,韩 真,邵丽梅,等.经肝动脉化疗栓塞术、经门静脉化疗栓塞术联合高强度聚焦超声治疗门静脉癌栓的临床研究[J].介入放射学杂志,2015,(03):256.
JI Yan lei,HAN Zhen,SHAO Li mei,et al.Combination use of TACE， PVE and HIFU for the treatment of portal vein cancerous thrombus： a clinical study[J].journal interventional radiology,2015,(09):256.
[15]施昌盛,杨 庆,乔彬彬,等.射频消融对TACE术后残余病灶的疗效分析 [J].介入放射学杂志,2016,(12):1097.
SHI Chang- sheng,YANG Qing,QIAO Bin- bin,et al.Radiofrequency ablation for the treatment of hepatic residuallesions after TACE： analysis of curative effect[J].journal interventional radiology,2016,(09):1097.
[16]董 健,陈奇峰,夏金国,等.TACE联合微波消融对比单独TACE治疗>5 cm原发性肝癌的倾向性匹配分析 [J].介入放射学杂志,2017,(10):894.
DONG Jian,CHEN Qifeng,XIA Jinguo,et al.TACE combined with microwave ablation versus pure TACE for hepatocellular carcinomas larger than five cm in diameter： a propensity matching analysis[J].journal interventional radiology,2017,(09):894.
[17]陈 荔,郭金和,朱光宇,等.比较香港肝癌分期和巴塞罗那肝癌分期对TACE后生存的预测作用 [J].介入放射学杂志,2017,(12):1088.
CHEN Li,GUO Jinhe,ZHU Guangyu,et al.Clinical value of liver cancer staging in predicting the survival time in Chinese patients after receiving TACE： comparison of Hong Kong liver cancer staging system with Barcelona clinic liver cancer staging system[J].journal interventional radiology,2017,(09):1088.
[18]寸江平,姜永能,宗 璇,等.CalliSpheres微球联合空白微球TACE治疗中晚期肝癌的近期疗效及安全性研究 [J].介入放射学杂志,2019,28(03):237.
CUN Jiangping,JIANG Yongneng,ZONG Xuan,et al.Transarterial chemoembolization by using CalliSpheres drug- eluting beads combined with 8Spheres microsphere for the treatment of advanced hepatocellular carcinoma： study on its short- term efficacy and safety[J].journal interventional radiology,2019,28(09):237.
[19]顾 杰,许 晨,周卫忠,等.TACE联合阿帕替尼对比单独TACE治疗中晚期原发性肝癌的倾向性匹配分析[J].介入放射学杂志,2021,30(07):724.
GU Jie,XU Chen,ZHOU Weizhong,et al.TACE combined with apatinib versus TACE alone for middle-stage and advanced hepatocellular carcinoma： a propensity matching analysis[J].journal interventional radiology,2021,30(09):724.
[20]张司马康,施海彬,周春高,等.中性粒细胞和淋巴细胞比值对原发性肝癌肝动脉化疗栓塞术后的预测价值[J].介入放射学杂志,2022,31(07):697.
ZHANG Simakang,SHI Haibin,ZHOU Chungao,et al.The value of neutrophil-to-lymphocyte ratio in predicting the survival time of patients with primary hepatocellular carcinoma treated with transhepatic arterial chemoembolization[J].journal interventional radiology,2022,31(09):697.